PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Alphatec Holdings, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Alphatec Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than almost all Healthcare companies in United States.
  • Cash Cushion Ratio: Debt, after subtracting cash, equals 25% of its market value (net debt). Lower than 87% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Where $100 of sales goes

$108Operating costs$6.0Interest$19Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-0.3×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 62% of Healthcare companies in United States.

Cash Locked Ratio

$29

For every $100 of sales, $29 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $36 tied up three years earlier.

More money tied up than 64% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

$2

Sales grew 118% in 3 years; of every extra $100 of sales, $2 became extra profit.

Lower than 65% of Healthcare companies in United States.

Asset Productivity Ratio

+118% / +52%

In 3 years sales changed by +118% while total assets changed by +52%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.7×

Debt due within a year is covered 0.7 times by its yearly operating cash.

Higher than 71% of Healthcare companies in United States.

Cash Cushion Ratio

−25%

Debt, after subtracting cash, equals 25% of its market value (net debt).

Lower than 87% of Healthcare companies in United States.

Tangible Assets Ratio

79%

Of every $100 the company owns, $79 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 53% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than almost all Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+39%

Share count rose 39% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 52% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Alphatec Holdings, Inc. made a loss over the last year. Alphatec Holdings, Inc. owes $1.02 for every $1 it owns. Alphatec Holdings, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Alphatec Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-142.18

Alphatec Holdings, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$1.7 B

The total market value of all of Alphatec Holdings, Inc.'s shares at today's price (share price × number of shares), larger than 72% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

Negative

Alphatec Holdings, Inc.'s net worth is negative ($12 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.

Return on equity (ROE)

-373.4%

Alphatec Holdings, Inc. lost 373.4% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.

Owes vs Owns

1.02×

Alphatec Holdings, Inc. owes $1.02 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.

Dividend yield

None

Alphatec Holdings, Inc. does not currently pay a dividend.

Revenue growth

+25%

Revenue rose 25% in the year to Dec 2025, and grew 30% a year on average over 3 years.

Profit growth

Loss

Alphatec Holdings, Inc. made a loss in each of the last two years.

Profit margin

-18.8%

Alphatec Holdings, Inc. lost $19 for every $100 of revenue.

Interest cover

Not covered

Alphatec Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Alphatec Holdings, Inc. had $435 M more debt than cash (net debt) at Dec 2025.

Questions

What is Alphatec Holdings, Inc.'s return on equity?

Alphatec Holdings, Inc. lost 373.4% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.

How much does Alphatec Holdings, Inc. owe compared with what it owns?

Alphatec Holdings, Inc. owes $1.02 for every $1 it owns, so it owes more than it owns, higher than 87% of Healthcare companies in United States.

Does Alphatec Holdings, Inc. pay a dividend?

No. Alphatec Holdings, Inc. does not currently pay a dividend.

Is Alphatec Holdings, Inc.'s revenue growing?

Revenue rose 25% in the year to Dec 2025, and grew 30% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.